Patient characteristics
Patient no. . | Prior Tx . | Rai stage . | ZAP-70 . | IgVh status . | Cytogenetics . | WBC, × 109/L . | Endogenous dGTP, μM . |
---|---|---|---|---|---|---|---|
1 | T | 2 | + | - | ND | 45 | 3.8 |
2 | UNT | 1 | - | ND | 46,XX{20} | 159 | 4.4 |
3 | UNT | 3 | - | ND | 46,XY{11] | 114 | 3.7 |
4 | UNT | 3 | + | - | 47,XX,+12[4]/46,XX[11] | 280 | 2.5 |
5 | UNT | 4 | - | + | 46,XY {20} | 360 | 0.3 |
6 | UNT | 0 | ND | ND | 46,XY,del{13} {q12q14} {7}/46,XY{13} | 43 | 0.9 |
7 | UNT | 1 | ND | ND | Random numeral and structural changes {2}/46,XY{18} | 78 | 0.9 |
8 | UNT | 1 | + | - | 46,XY {20} | 52 | 0.8 |
9 | UNT | 1 | ND | ND | 46,XX{12} | 243 | 3.1 |
10 | UNT | 2 | - | + | 46,XX {20} | 127 | 2.7 |
11 | UNT | 1 | + | ND | ND | 35 | ND |
12 | T | 3 | - | ND | 46,XY {15} | 228 | 1.0 |
Patient no. . | Prior Tx . | Rai stage . | ZAP-70 . | IgVh status . | Cytogenetics . | WBC, × 109/L . | Endogenous dGTP, μM . |
---|---|---|---|---|---|---|---|
1 | T | 2 | + | - | ND | 45 | 3.8 |
2 | UNT | 1 | - | ND | 46,XX{20} | 159 | 4.4 |
3 | UNT | 3 | - | ND | 46,XY{11] | 114 | 3.7 |
4 | UNT | 3 | + | - | 47,XX,+12[4]/46,XX[11] | 280 | 2.5 |
5 | UNT | 4 | - | + | 46,XY {20} | 360 | 0.3 |
6 | UNT | 0 | ND | ND | 46,XY,del{13} {q12q14} {7}/46,XY{13} | 43 | 0.9 |
7 | UNT | 1 | ND | ND | Random numeral and structural changes {2}/46,XY{18} | 78 | 0.9 |
8 | UNT | 1 | + | - | 46,XY {20} | 52 | 0.8 |
9 | UNT | 1 | ND | ND | 46,XX{12} | 243 | 3.1 |
10 | UNT | 2 | - | + | 46,XX {20} | 127 | 2.7 |
11 | UNT | 1 | + | ND | ND | 35 | ND |
12 | T | 3 | - | ND | 46,XY {15} | 228 | 1.0 |
Tx indicates therapy; T, Treated; UNT, untreated; and ND, not done.